Semaglutide and tirzepatide may still be little-used names outside the medical offices, but Ozempic and Moungharo have become commonplace at dinner tables, messaging applications and social networks. Popularized as "smoothing pens", these injectable drugs have gained visibility in recent years in the midst of the increase in obesity in the country, which increased from 11.8% in 2006 to 25.7% in 2024, according to the Vigitel 2006-2024 research o…
Semaglutide and tirzepatide may still be little-used names outside the medical offices, but Ozempic and Moungharo have become commonplace at dinner tables, messaging applications and social networks. Popularized as "smoothing pens", these injectable drugs have gained visibility in recent years in the midst of the increase in obesity in the country, which increased from 11.8% in 2006 to 25.7% in 2024, according to the Vigitel 2006-2024 research o…